Navigation Links
Curemark Appoints Preeminent Pediatrics Gastroenterologist
Date:12/18/2007

RYE, N.Y., Dec. 18 /PRNewswire/ -- Curemark's Board of Directors announced today that Steven M. Schwarz, MD, FAAP, FACN, AGAF, will join the company as a senior scientist and will serve on the company's Scientific Advisory Board. Dr. Schwarz is presently Chairman of the Department of Pediatrics at The Long Island College Hospital and Professor of Pediatrics at the State University of New York Health Science Center at Brooklyn.

"Dr. Schwartz is one of America's foremost authorities on pediatric gastroenterology," states Dr. Joan Fallon, Curemark's CEO. "Having Dr. Schwarz as an integral part of Curemark will assist the company greatly as we prepare for autism clinical trials scheduled for the early part of 2008. His vast expertise in the areas of gastroenterology and developmental disabilities is a perfect fit with Curemark's research and proprietary work in pediatric dysautonomia, autism and ADHD."

A graduate of Yale College and Columbia University's College of Physicians and Surgeons, Dr. Schwarz received his training in Pediatrics and Pediatric Gastroenterology and Nutrition at Columbia and Stanford Universities. Dr. Schwarz served on the faculty of the Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine from 1980-84, and at New York Medical College from 1984-95. At New York Medical College, he was awarded the Charles H. Revson Foundation Career Scientist Award. In 1995 he was named Distinguished Lecturer in the Graduate School of Health Sciences.

Curemark, with offices in Rye, NY, is a drug development company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of key enzymes in autistic children. She has identified and patented a series of biomarkers that delineate which autistic patients may have digestive deficiencies underlying their disease. Curemark is the first company to deliver upon the connection between a variety of conditions, including autism, ADD/ADHD, Parkinson's and others that have roots in the gastrointestinal tract. To learn more about our innovative science, visit http://www.Cure-Mark.com.

Media Contact:

Kate Taylor

914-925-3450

Investment Contact:

Ken Nanus

914-450-0816

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Curemark
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/9/2016)... 9, 2016  Forge Therapeutics, Inc. today announced ... Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance its ... treatment of bacterial infections including those caused by ... an attractive antibacterial target for more than the ... chemical starting points has hampered its progress. Forge ...
(Date:12/8/2016)... 8, 2016 Australia Ophthalmic Lasers Market Outlook ... Ophthalmic Lasers Market Outlook to 2022", provides key market ... provides value, in millions of US dollars, volume (in ... Excimer Lasers, Femtosecond Lasers and YAG Lasers. The ... for each of these market segements, and global corporate-level ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 10, 2016 , ... "TransPanel Volume 2 is ... unique animations," said Christina Austin - CEO of Pixel Film Studios. , TransPanel ... FCPX . This set of versatile transitions features presets with up to ...
(Date:12/10/2016)... PITTSBURGH, PA (PRWEB) , ... December 10, 2016 , ... ... Jacksonville, Fla., worried about germs spreading from the seat to her body, and contamination ... but convenient and effective way to solve this problem that many people face. , ...
(Date:12/9/2016)... ... 2016 , ... Cellairis is a worldwide mobile device and computer repair franchise ... iPad and Samsung Galaxy devices with premium parts and accessories. Cellairis has recently ... and accessibility for customers. While customers do their shopping, Cellairis can accomplish a number ...
(Date:12/9/2016)... ... 2016 , ... The Justin Veatch Fund announced Thursday that ... film Whispering Spirits and its discussion guide for use by all of ... in the war against teen drug abuse. NCADD is the oldest anti-addiction advocacy ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution ... transplantation while encouraging readers to sign up as an organ donor for the 123,000 ... , An organ donor can save up to 8 saves through organ donation ...
Breaking Medicine News(10 mins):